EDIT vs GNRC · rev $32.3M vs P/E 82, rev $4.21B
Editas Medicine Inc (EDIT) versus Generac Holdings Inc (GNRC) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported GNRC revenue for 2025-12-31 was $4.21B. Net income was $159.6M. Revenue was down 2.0% from 2024-12-31 to 2025-12-31. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
EDIT currently screens at market cap $375.2M. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Not investment advice. Open the EDIT and GNRC stock pages for the full models.
Not investment advice.